Cryptococcosis is an opportunistic infection, the incidence of which is increased in the immunocompromised patients. Cryptococcus neoformans is an encapsulated fungus that mainly infects the lungs and the central nervous system, possibly involving different organs. Cutaneous cryptococcosis is classified into localized infection, usually occurring after traumatic inoculation (primary cutaneous cryptococcosis) and cutaneous manifestation due to hematogenous dissemination (secondary cutaneous cryptococcosis), mostly in patients with underlying immunosuppression. We report a case of cutaneous cryptococcosis in a patient affected by chronic lymphocytic leukaemia.
SpeedBDuntD. Clinical and host difference between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis1995; 21:28–32.
2.
QuereuxGMilpiedBMorinOAndresPParantEPoirierPRappMJStalderJF. Primary cutaneous cryptococcosis in HIV-negative patients. Ann Dermatol Venereol2001; 128:1009–12.
3.
TakusMJ. Experimental cryptococcosis produced by the injection of virulent organism. N Engl J Med1956; 245:598–604.
4.
HuttoJOBryanCSGreneFLWhiteCJGallinJI. Cryptococcosis of the colon resembling Crohn's disease in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology1988; 94:808–11.
5.
RevengaFParicioJFMerinoFJNebredaTRamirezTMartinezAM. Primary cutaneous cryptococcosis in an immunocompetent host: case report and review of the literature. Dermatology2002; 204:145–50.
ChristiansonJCEngberWAndesD. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol2003; 41:177–81.
8.
LevitzSM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis1991; 13:1163.
9.
KontoyiannisDPPeitschWKReddyBTWhimbeyEEHanXYBodeyGPRolstonKV. Cryptococcosis in patients with cancer. Clin Infect Dis2001; 32:145–49.
10.
GendelBREndeMNormanSL. Cryptococcosis. A review with special reference to apparent association with Hodgkin's disease. Am J Med1950; 9:343–48.
11.
SepkowitzKA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis2002; 34:1098.
12.
WhiteMCirrincioneCBlevinsAArmstrongD. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis1992; 165:960–65.
13.
BirkettDAMcMurrayJ. Cutaneous cryptococcosis. Proc R Soc Med1976; 69:515.
14.
CrounseRGLernerAB. Cryptococcosis case with unusual skin lesions and favourable response to amphotericin B therapy. Arch Dermatol1958; 77:210–14.
BortonLKWintroubBU. Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol1984; 10:387–91.
17.
ConcusAPHelfandRFImberMJLernerEASharpeRJ. Cutaneous cryptococcosis mimicking molluscum contagiosum in a patient with AIDS. J Infect Dis1988; 158:897–902.
IngletonRKoestenblattEDonPLevyHSzaniawskiWWeinbergJM. Cutaneous cryptococcosis mimicking basal cell carcinoma in a patient with AIDS. J Cutan Med Surg1998; 3:43–48.
20.
CokerLRSwainRMorrisRMcCallCO. Disseminated cryptococcosis presenting as pseudofolliculitis in an AIDS patient. Cutis2000; 66:207–11.
21.
YawalkarNFerencziKJonesDAYamanakaKSuhKYSadatSKupperTS. Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood2003; 102:4059–63.
22.
SchupbachCWWheelerCEBriggamanRAWarnerNAKanafEP. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol1976; 112:1734–39.
BuschkeAJosephA. Blastomycosis. In Handbuch der Hautz und Geschlechtskrankheiten. Vol. II. JadassohnJ., ed. Springer-VerlagBerlin, 1928; p. 1.
25.
NgWFLooKT. Cutaneous cryptococcosis—primary versus secondary disease: report of two cases and review of the literature. Am J Dermatopathol1993; 15:372–84.
26.
PaugamADupouy-CametJBlanchePGangneuxJPTourte-SchaeferCSicardD. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis1994; 19:975–81.
27.
AllerAIMartin-MazuelosELozanoFGomez-MateosJSteele-MooreLHollowayWJGutierrezMJRecioFJEspinel-IngroffA. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother2000; 44:1544–49.
28.
HobanDJZhanelGGKarlowskyJA. In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients. Antimicrob Agents Chemother1999; 43:1463–66.
29.
Orni-WasserlaufRIzkhakovESiegman-IgraYBashEPolacheckIGiladiM. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole. Clin Infect Dis1999; 29:1592–97.
30.
MondonPPetterRAmalfitanoGLuzzatiRConciaEPolacheckIKwon-ChungKJ. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother1999; 43:1856–61.
31.
AssingKBirgensHArendrupM. Cryptococcus neoformans var. neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukaemia. Clin Microbiol Infect2003; 9:441–48.
32.
MirzaSAPhelanMRimlandDGravissHamillRBrandtMEGardneretTSattahMde LeonGPBaughmanWHajjehRA. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis2003; 36:789–95.
